Warning: China Launches AI Attack on America

China just launched what can only be described as an AI attack on America. And according to Louis Navellier, the legendary investor who picked Nvidia before shares exploded as high as 3,423%... President Trump is already planning a counter attack. And it's creating an incredible opportunity for you in this small group of AI stocks.

Eventful Monday For AstraZeneca - What's Going On?

Vandana Singh
March 17, 2025

On Monday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the CALYPSO Phase 3 trial designed to evaluate the efficacy and safety of eneboparatide in adults with chronic hypoparathyroidism.

The study showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary endpoint with statistical significance at 24 weeks in adults with chronic hypoparathyroidism (HypoPT) compared to placebo.

The primary endpoint is a composite of normalization of albumin-adjusted serum calcium levels and independence from active vitamin D and oral calcium therapy.

Also Read: AstraZeneca’s Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients

HypoPT is a rare endocrine disease caused by a deficiency of PTH and is characterized by impaired regulation of calcium and phosphate levels in the blood. Eneboparatide was well tolerated.

After the 24-week randomized treatment period, all patients receive eneboparatide in the ongoing long-term extension until 52 weeks. Full efficacy and safety data will be analyzed at 52 weeks.

Concurrently, AstraZeneca and Alteogen entered into an exclusive license agreement for ALT-B4, a hyaluronidase utilizing Hybrozyme platform technology.

Under the terms of the agreement, AstraZeneca will acquire worldwide rights to use ALT-B4 to develop and commercialize subcutaneous formulations of several oncology assets.

Alteogen will be responsible for the clinical and commercial supply of ALT-B4 to AstraZeneca.

AstraZeneca will pay Alteogen an upfront payment and additional payments upon achieving specific development, regulatory, and sales-related milestones. Additionally, Alteogen will receive royalties on the sales of the commercialized products.

On Monday, the European Union approved AstraZeneca’s Imfinzi (durvalumab) as monotherapy for adults with limited-stage small cell lung cancer whose disease has not progressed following platinum-based chemoradiation therapy.

The approval is based on results from the ADRIATIC Phase 3 trial.

The trial showed that Imfinzi reduced the risk of death by 27% compared to placebo.

The estimated median overall survival was 55.9 months for Imfinzi versus 33.4 months for placebo. An estimated 57% of patients treated with Imfinzi were alive at three years compared to 48% for placebo.

Imfinzi also reduced the risk of disease progression or death by 24% versus placebo.

The median progression-free survival (PFS) was 16.6 months for Imfinzi versus 9.2 months for placebo. An estimated 46% of patients treated with Imfinzi had not experienced disease progression at two years compared to 34% for placebo.

Earlier on Monday, AstraZeneca agreed to acquire cell therapy focused-EsoBiotec SA for up to $1 billion.

Price Action: At the last check on Monday, AZN stock was down 1.04% to $76.78 during the premarket session.

Read Next:

  • Hain Celestial Valuation Is Low Versus Historical Levels, But Analyst Remains Neutral – Here’s Why

Image by Robert Way via Shutterstock

Continue Reading...

Popular

Cathie Wood Goes On Shopping Spree Amid Tech Bloodbath Monday: Loads Up On Tesla, Palantir, Coinbase And These Stocks

On Monday, Cathie Wood‘s Ark Invest made significant trades involving Tesla Inc. (NASDAQ:TSLA) , Palantir Technologies Inc. (NASDAQ:PLTR), Coinbase Global Inc. (N

India and New Zealand look to bolster ties after reviving free trade talks

NEW DELHI (AP) — Indian Prime Minister Narendra Modi and his New Zealand counterpart, Christopher Luxon, met Monday seeking to deepen their defense and economic ties, a day after the countries announced the revival of negotiations for a free trade agreement.

Just Released: Huge New A.I. Trade - Ad

While everyone's distracted by Nvidia, PLTR & Bitcoin, billionaires have been quietly loading up on this stock. And 99% of Americans have no clue. It could help make a fortune for fast-moving investors, who make their move before March 19.

NBA Legend Shaq's Walmart Shopping Spree Ends In Credit Card Decline - Here's How Much He Tried To Spend

Basketball superstar Shaquille O'Neal's impact goes beyond basketball, with his larger-than-life personality and smart investments. Yet, one of his most unforgettable moments happened at Walmart.

Law firm sues over Trump executive order that seeks to suspend security clearances

WASHINGTON (AP) — A during the 2016 presidential campaign sued the federal government Tuesday over an executive order that seeks to strip its attorneys of security clearances.

Are you owed an extra $2,105 a month in extra cash? - Ad

A little-known "loophole" has allowed a handful of regular Americans to legally collect over $109,200,000 in bonus cash. And today's your chance to join them. It doesn't matter how old you are or even how much money you make. And my research shows there's no way you can be denied from taking part in this opportunity.

This 'Dune' isn't fiction. It's the longest conveyer belt in the US and moving sand in Texas

KERMIT, Texas (AP) — It's longer than the width of Rhode Island, snakes across the oil fields of the southwest U.S. and crawls at 10 mph – too slow for a truck and too long for a train.

Trump, Musk & the Gold Play No One Sees Coming - Ad

Fort Knox mystery could send gold skyrocketing. Because the real danger isn't missing gold. It's decades of Fed manipulation collapsing overnight. Right now, I've uncovered 5 major gold predictions that could make this Fort Knox moment even bigger than people realize. One of them is already unfolding.

Warren Buffett on Debt and Donald Trump's Money Moves: Trump 'Never Went Right'

In a piece of advice that continues to hold relevance, investor Warren Buffett once warned students about the perils of excessive borrowing, citing Donald Trump as a case in point.

China is ending its annual Congress with questions open over how to revive its slowing economy

BEIJING (AP) — China is wrapping up its biggest political event of the year on Tuesday leaving one question unanswered: How far will it go to try to revive economic growth in 2025?

The Billionaire Bet That Could Change Uranium Forever - Ad

The world's richest investors--Gates, Bezos, Altman--are pouring billions into nuclear energy. With uranium demand surging, one tiny uranium junior could potentially be the next big winner.

Tesla's China Boom, Rivian's Sweet Ride, And Trump's Tariffs Threat: This Week In Mobility

The EV industry saw major developments over the weekend, with Tesla's Model Y surging in China, its Model S/X retreating from Japan, Rivian unveiling its Georgia timeline and an ice cream truck partnership, and Trump's tariffs threatening the profits of Detroit's Big Three automakers.

Debts, Deficits & Destruction of the US Dollar - Ad

The economist Time Magazine called "out of step with economic reality" for predicting the U.S. economy would implode in his 2005 best-selling book Empire of Debt over two years before the Financial Crisis tore America and the global economy apart... is back to issue his next warning. Before you invest a single dollar in the markets -- or make any investment decisions -- it's critical you see this alarming video right away.

A Chinese shipyard completes a second submarine for ally Pakistan

TAIPEI, Taiwan (AP) — A Chinese shipyard has completed a second submarine for the Pakistan navy, further strengthening military

The "Second Wave" of 2025 Crashes (Could Be Worst in Us History) - Ad

According to the man who predicted 2008, 2020, and 2022... A new wave of crashes are coming to the US stock market. But these will be different. The moment they hit, they could kick off the worst (and longest) financial crisis in American history.

Who is Mark Carney, the next prime minister of Canada?

TORONTO (AP) — Former central banker Mark Carney will become Canada’s next prime minister after a Liberal Party leadership vote in a landslide.

A Tiny Uranium Stock Positioned for a Big Breakout - Ad

A junior miner with high-grade uranium assets in Canada's Athabasca Basin and Central Mineral Belt is making moves. Plans are in motion, and the uranium market is heating up. Could this be the next UEC?

AOC Claps Back At Mike Johnson As Senate Moves Closer To Government Shutdown: 'If You Need Democrats, Then You Need To Negotiate'

Alexandria Ocasio-Cortez pushed back on Speaker Mike Johnson's blame for a possible shutdown, reminding him that Republicans control the government and must negotiate if they lack the votes.

Edmunds: 2025 Honda CR-V vs. 2025 Subaru Forester

The is a redesigned model, but Subaru didn’t exactly stray from the formula of the last generation. It’s still a boxy small SUV with great visibility, adventure-ready versatility, and a no-nonsense approach to interior design. Its many upgrades for 2025 help keep it competitive, but how does it fare against the class best?

Wall Street Legend Now Calling Exact Day Next Market Crash Will Start? - Ad

Perhaps no one on or off Wall Street has more accurate in calling the market turns of the past 7 years. From the bear markets of 2018 and 2022... to the roaring bull runs of 2021, 2023, and 2024. And now, Marc Chaikin is predicting the exact month (even the exact day!) the next crash is most likely to start--don't miss this huge and important new call.

Critics warn staff cuts at federal agencies overseeing US dams could put public safety at risk

COULEE DAM, Wash. (AP) — Trump administration workforce cuts at federal agencies overseeing U.S. dams are threatening their ability to provide reliable electricity, supply farmers with water and protect communities from floods, employees and industry experts warn.

Australia won't retaliate against 'unjustified' US tariffs on steel and aluminum

MELBOURNE, Australia (AP) — Australian Prime Minister said Wednesday that U.S. tariffs on Australian steel and aluminum were unjustified, but his government would not retaliate with its own tariffs.

Bill Gates' Next Big AI Bet: Stargate Could Be a Game-Changer - Ad

Jeff Brown, the tech expert who predicted Bitcoin, Nvidia, and Tesla, reveals Bill Gates' new AI project, Stargate. Could this be the next big AI breakthrough?

What's Going On With Gap Stock Friday?

Gap stock is trading higher on Friday after the company reported fourth-quarter earnings on Thursday after the market closed.

Intel Beats Investor Lawsuit After $32 Billion Stock Plunge - Judge Rules Foundry Losses Weren't Misleading

Intel secured a legal victory after a U.S. judge dismissed a shareholder lawsuit alleging the company misled investors about foundry losses, which contributed to a $32 billion stock plunge.

[Revealed] Trump and Elon's Shocking New Plan for America - Ad

Three patents could help President Trump and Elon Musk completely revolutionize a $23 Trillion market. This revolution is about so much more than just self-driving cars. Instead, what Elon's pivoting Tesla towards... Is a market that's 1,000X BIGGER. But a project THIS big can't stay under the radar for long...

Eat grass-fed beef, help the planet? Research says not so simple

For cattle fattened in fields instead of feedlots, the grass may be greener, but the carbon emissions are not.

The $240M AI Disruptor - Ad

This Nasdaq-listed company is redefining AI in the $124 billion smart glass market. From cockpit shading systems to energy-efficient building glass, their technology powers global leaders like Boeing, Mercedes-Benz, and National Geographic. Their projected $240M revenue from aerospace positions them as an AI-driven market disruptor you can't ignore.

Magnificent 7 Sheds Over $750 Billion In Market Cap In One Day: Is Big Tech's Honeymoon Over? (CORRECTED)

The Magnificent Seven tech companies, including Tesla, which make up 30% of the S&P 500, saw major losses on Monday due to recession fears.

Chuck Schumer Blames GOP For 'Partisan Path' As Shutdown Nears - Republicans Say 'Democrats' Fault' If Government Closes

Congressional leaders exchanged sharp criticisms Wednesday as the federal government faces a potential shutdown within days, highlighting the partisan divide over spending priorities and negotiation tactics.

A Uranium Boom Is Coming--Are You Positioned? - Ad

The last uranium cycle created massive winners. This new bull market is just beginning, and one tiny uranium stock could be a major beneficiary.

Trump vs Musk? Federal Workers Unconvinced He'll Take Action: 'If They Don't Cut, Elon will, Comments Show Who's Really In Charge'

President Donald Trump has reportedly limited the authority of his billionaire advisor, Elon Musk, to dismiss federal employees. This development has stirred skepticism among the workforce and political circles.

Which US companies are pulling back on diversity initiatives?

A growing number of prominent companies have scaled back or set aside the diversity, equity and inclusion initiatives that endorsed following the protests that accompanied the Minneapolis police killing of George Floyd, a Black man, in 2020.

AI + Smart Glass = A Nasdaq Sleeper - Ad

This recent Nasdaq IPO is quietly making waves, thanks to its 95% market share in a $240M aerospace niche. With patented technology that integrates AI into smart glass, this company is poised for massive growth as the market races toward $124 billion by 2029.

Asana Growth Materially Lags Peers, JP Morgan Cuts Price Forecast

Asana's stock (NYSE: ASAN) fell following price target cuts by Wall Street firms despite beating earnings estimates and reporting strong revenue.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service